Mechanism of interaction of ticlopidine and its analogues with the energy-conserving mechanism in mitochondria

Samir Abou-Khalil, Wafa H. Abou-Khalil, Adel A Yunis

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

It was shown recently that the antiaggregating agent ticlopidine and some of its analogues inhibit the energy-conserving mechanism in mitochondria [Abou-Khalil et al., Biochem. Pharmac. 33, 3893 (1984)]. In the present investigation, the mechanism of inhibition by these drugs was investigated by studying their effects on key reactions of oxidative phosphorylation. Liver mitochondria were isolated from Sprague-Dawley male rats, and the interactions of ticlopidine and six of its analogues with those key reactions were tested. We found: (A) The transport of phosphate, glutamate and succinate into mitochondria was not affected significantly by ticlopidine or any of its analogues; however, it was inhibited by both mersalyl and N-ethylmaleimide as expected. (B) There was no inhibitory effect of the tested drugs on the mitochondrial [3H]ADP translocation activity; rather, ticlopidine produced a concentration-dependent increase of that activity, reaching 54% with 20 μg/ml. (C) Ticlopidine and its analogue, PCR 5325, increased the latent ATPase activity by about 400% and the DNP-dependent ATPase by about 50%. Also, PCR 4099 caused a 115% increase in the latent activity, whereas the effects of the remaining analogues varied from slight activation to slight inhibition. (D) Under non-phosphorylation conditions, the mitochondrial H+ extrusion resulting from succinate oxidation was inhibited by ticlopidine in a concentration-dependent manner reaching a quasi total inhibition with 40 μg/ml. While PCR 5325 gave results similar to ticlopidine, PCR 4099 was less inhibitory and the other analogues were ineffective. These data indicate that the inhibitory action caused by ticlopidine and some of its analogues on oxidative phosphorylation does not reside at one particular site in the mitochondrial membrane; rather, the inhibition seems to be the outcome of profound alterations in mitochondrial ADP translocase, latent ATPase, and proton translocation in the respiratory chain.

Original languageEnglish (US)
Pages (from-to)1855-1859
Number of pages5
JournalBiochemical Pharmacology
Volume35
Issue number11
DOIs
StatePublished - Jun 1 1986

Fingerprint

Ticlopidine
Mitochondria
clopidogrel
Adenosine Triphosphatases
Oxidative Phosphorylation
Succinic Acid
Mersalyl
ATP Translocases Mitochondrial ADP
Polymerase Chain Reaction
Ethylmaleimide
Liver Mitochondrion
Mitochondrial Membranes
Electron Transport
Pharmaceutical Preparations
Liver
Adenosine Diphosphate
Extrusion
Sprague Dawley Rats
Protons
Rats

ASJC Scopus subject areas

  • Pharmacology

Cite this

Mechanism of interaction of ticlopidine and its analogues with the energy-conserving mechanism in mitochondria. / Abou-Khalil, Samir; Abou-Khalil, Wafa H.; Yunis, Adel A.

In: Biochemical Pharmacology, Vol. 35, No. 11, 01.06.1986, p. 1855-1859.

Research output: Contribution to journalArticle

Abou-Khalil, Samir ; Abou-Khalil, Wafa H. ; Yunis, Adel A. / Mechanism of interaction of ticlopidine and its analogues with the energy-conserving mechanism in mitochondria. In: Biochemical Pharmacology. 1986 ; Vol. 35, No. 11. pp. 1855-1859.
@article{c425e57e7cb3484ebf95e686081607f7,
title = "Mechanism of interaction of ticlopidine and its analogues with the energy-conserving mechanism in mitochondria",
abstract = "It was shown recently that the antiaggregating agent ticlopidine and some of its analogues inhibit the energy-conserving mechanism in mitochondria [Abou-Khalil et al., Biochem. Pharmac. 33, 3893 (1984)]. In the present investigation, the mechanism of inhibition by these drugs was investigated by studying their effects on key reactions of oxidative phosphorylation. Liver mitochondria were isolated from Sprague-Dawley male rats, and the interactions of ticlopidine and six of its analogues with those key reactions were tested. We found: (A) The transport of phosphate, glutamate and succinate into mitochondria was not affected significantly by ticlopidine or any of its analogues; however, it was inhibited by both mersalyl and N-ethylmaleimide as expected. (B) There was no inhibitory effect of the tested drugs on the mitochondrial [3H]ADP translocation activity; rather, ticlopidine produced a concentration-dependent increase of that activity, reaching 54{\%} with 20 μg/ml. (C) Ticlopidine and its analogue, PCR 5325, increased the latent ATPase activity by about 400{\%} and the DNP-dependent ATPase by about 50{\%}. Also, PCR 4099 caused a 115{\%} increase in the latent activity, whereas the effects of the remaining analogues varied from slight activation to slight inhibition. (D) Under non-phosphorylation conditions, the mitochondrial H+ extrusion resulting from succinate oxidation was inhibited by ticlopidine in a concentration-dependent manner reaching a quasi total inhibition with 40 μg/ml. While PCR 5325 gave results similar to ticlopidine, PCR 4099 was less inhibitory and the other analogues were ineffective. These data indicate that the inhibitory action caused by ticlopidine and some of its analogues on oxidative phosphorylation does not reside at one particular site in the mitochondrial membrane; rather, the inhibition seems to be the outcome of profound alterations in mitochondrial ADP translocase, latent ATPase, and proton translocation in the respiratory chain.",
author = "Samir Abou-Khalil and Abou-Khalil, {Wafa H.} and Yunis, {Adel A}",
year = "1986",
month = "6",
day = "1",
doi = "10.1016/0006-2952(86)90303-5",
language = "English (US)",
volume = "35",
pages = "1855--1859",
journal = "Biochemical Pharmacology",
issn = "0006-2952",
publisher = "Elsevier Inc.",
number = "11",

}

TY - JOUR

T1 - Mechanism of interaction of ticlopidine and its analogues with the energy-conserving mechanism in mitochondria

AU - Abou-Khalil, Samir

AU - Abou-Khalil, Wafa H.

AU - Yunis, Adel A

PY - 1986/6/1

Y1 - 1986/6/1

N2 - It was shown recently that the antiaggregating agent ticlopidine and some of its analogues inhibit the energy-conserving mechanism in mitochondria [Abou-Khalil et al., Biochem. Pharmac. 33, 3893 (1984)]. In the present investigation, the mechanism of inhibition by these drugs was investigated by studying their effects on key reactions of oxidative phosphorylation. Liver mitochondria were isolated from Sprague-Dawley male rats, and the interactions of ticlopidine and six of its analogues with those key reactions were tested. We found: (A) The transport of phosphate, glutamate and succinate into mitochondria was not affected significantly by ticlopidine or any of its analogues; however, it was inhibited by both mersalyl and N-ethylmaleimide as expected. (B) There was no inhibitory effect of the tested drugs on the mitochondrial [3H]ADP translocation activity; rather, ticlopidine produced a concentration-dependent increase of that activity, reaching 54% with 20 μg/ml. (C) Ticlopidine and its analogue, PCR 5325, increased the latent ATPase activity by about 400% and the DNP-dependent ATPase by about 50%. Also, PCR 4099 caused a 115% increase in the latent activity, whereas the effects of the remaining analogues varied from slight activation to slight inhibition. (D) Under non-phosphorylation conditions, the mitochondrial H+ extrusion resulting from succinate oxidation was inhibited by ticlopidine in a concentration-dependent manner reaching a quasi total inhibition with 40 μg/ml. While PCR 5325 gave results similar to ticlopidine, PCR 4099 was less inhibitory and the other analogues were ineffective. These data indicate that the inhibitory action caused by ticlopidine and some of its analogues on oxidative phosphorylation does not reside at one particular site in the mitochondrial membrane; rather, the inhibition seems to be the outcome of profound alterations in mitochondrial ADP translocase, latent ATPase, and proton translocation in the respiratory chain.

AB - It was shown recently that the antiaggregating agent ticlopidine and some of its analogues inhibit the energy-conserving mechanism in mitochondria [Abou-Khalil et al., Biochem. Pharmac. 33, 3893 (1984)]. In the present investigation, the mechanism of inhibition by these drugs was investigated by studying their effects on key reactions of oxidative phosphorylation. Liver mitochondria were isolated from Sprague-Dawley male rats, and the interactions of ticlopidine and six of its analogues with those key reactions were tested. We found: (A) The transport of phosphate, glutamate and succinate into mitochondria was not affected significantly by ticlopidine or any of its analogues; however, it was inhibited by both mersalyl and N-ethylmaleimide as expected. (B) There was no inhibitory effect of the tested drugs on the mitochondrial [3H]ADP translocation activity; rather, ticlopidine produced a concentration-dependent increase of that activity, reaching 54% with 20 μg/ml. (C) Ticlopidine and its analogue, PCR 5325, increased the latent ATPase activity by about 400% and the DNP-dependent ATPase by about 50%. Also, PCR 4099 caused a 115% increase in the latent activity, whereas the effects of the remaining analogues varied from slight activation to slight inhibition. (D) Under non-phosphorylation conditions, the mitochondrial H+ extrusion resulting from succinate oxidation was inhibited by ticlopidine in a concentration-dependent manner reaching a quasi total inhibition with 40 μg/ml. While PCR 5325 gave results similar to ticlopidine, PCR 4099 was less inhibitory and the other analogues were ineffective. These data indicate that the inhibitory action caused by ticlopidine and some of its analogues on oxidative phosphorylation does not reside at one particular site in the mitochondrial membrane; rather, the inhibition seems to be the outcome of profound alterations in mitochondrial ADP translocase, latent ATPase, and proton translocation in the respiratory chain.

UR - http://www.scopus.com/inward/record.url?scp=0022549119&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022549119&partnerID=8YFLogxK

U2 - 10.1016/0006-2952(86)90303-5

DO - 10.1016/0006-2952(86)90303-5

M3 - Article

C2 - 2941020

AN - SCOPUS:0022549119

VL - 35

SP - 1855

EP - 1859

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

SN - 0006-2952

IS - 11

ER -